Literature DB >> 32544035

Substantia Nigra Volumetry with 3-T MRI in De Novo and Advanced Parkinson Disease.

Paolo Vitali1, Marina I Pan1, Fulvia Palesi1, Giancarlo Germani1, Arianna Faggioli1, Nicoletta Anzalone1, Pietro Francaviglia1, Brigida Minafra1, Roberta Zangaglia1, Claudio Pacchetti1, Claudia A M Gandini Wheeler-Kingshott1.   

Abstract

Background Magnetization transfer-prepared T1-weighted MRI can depict a hyperintense subregion of the substantia nigra involved in the degeneration process of Parkinson disease. Purpose To evaluate quantitative measurement of substantia nigra volume by using MRI to support clinical diagnosis and staging of Parkinson disease. Materials and Methods In this prospective study, a high-spatial-resolution magnetization transfer-prepared T1-weighted volumetric sequence was performed with a 3-T MRI machine between January 2014 and October 2015 for participants with de novo Parkinson disease, advanced Parkinson disease, and healthy control participants. A reproducible semiautomatic quantification analysis method that entailed mesencephalic intensity as an internal reference was used for hyperintense substantia nigra volumetry normalized to intracranial volume. A general linear model with age and sex as covariates was used to compare the three groups. Results Eighty participants were evaluated: 20 healthy control participants (mean age ± standard deviation, 56 years ± 11; 11 women), 29 participants with de novo Parkinson disease (64 years ± 10; 19 men), and 31 participants with advanced Parkinson disease (60 years ± 9; 16 women). Volumetric measurement of hyperintense substantia nigra from magnetization transfer-prepared T1-weighted MRI helped differentiate healthy control participants from participants with advanced Parkinson disease (mean difference for ipsilateral side, 64 mm3 ± 14, P < .001; mean difference for contralateral side, 109 mm3 ± 14, P < .001) and helped distinguish healthy control participants from participants with de novo Parkinson disease (mean difference for ipsilateral side, 45 mm3 ± 15, P < .01; mean difference for contralateral side, 66 mm3 ± 15, P < .001) and participants with de novo Parkinson disease from those with advanced Parkinson disease (mean difference for ipsilateral side, 20 mm3 ± 13, P = .40; mean difference for contralateral side, 43 mm3 ± 13, P = .004). Conclusion Magnetization transfer-prepared T1-weighted MRI volumetry of the substantia nigra helped differentiate the stages of Parkinson disease. © RSNA, 2020 Online supplemental material is available for this article.

Entities:  

Year:  2020        PMID: 32544035     DOI: 10.1148/radiol.2020191235

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  3 in total

1.  Early-stage Parkinson's disease: Abnormal nigrosome 1 and 2 revealed by a voxelwise analysis of neuromelanin-sensitive MRI.

Authors:  Young Hee Sung; Young Noh; Eung Yeop Kim
Journal:  Hum Brain Mapp       Date:  2021-03-10       Impact factor: 5.038

2.  A meta-analysis of accuracy and sensitivity of chest CT and RT-PCR in COVID-19 diagnosis.

Authors:  Fatemeh Khatami; Mohammad Saatchi; Seyed Saeed Tamehri Zadeh; Zahra Sadat Aghamir; Alireza Namazi Shabestari; Leonardo Oliveira Reis; Seyed Mohammad Kazem Aghamir
Journal:  Sci Rep       Date:  2020-12-28       Impact factor: 4.379

3.  Correlation between early features and prognosis of symptomatic COVID-19 discharged patients in Hunan, China.

Authors:  Yeyu Cai; Jiayi Liu; Haitao Yang; Taili Chen; Qizhi Yu; Juan Chen; Deng Huang; Zhu Chen; Quan-Liang Shang; Cong Ma; Xiangyu Chen; Enhua Xiao
Journal:  Sci Rep       Date:  2021-02-22       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.